Patent · US Active

PPAR agonists

US11420934B2 · kind B2 · utility

0Cited by
2References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 16, 2019
Grant dateAug 23, 2022
Priority date—
Expiry dateDec 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds and compositions useful in increasing PPARδ activity. The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.